
Scott Power: ASX health falls as Trump revives pharma import tariff threat; CSL ‘undervalued’
Health investors feel the heat as Trump renews pharma tariff talks. Pic via Getty Images ASX health stocks fall o.92% over past five days as US President Donald Trump renews tariff threat on pharmaceutical imports Morgans believes ASX’s biggest biotech CSL …